Regeneron Updates Conference Presentation Time for Investors

Author: Henry Turner Updated: 09-04-2025 04:17 PM

Regeneron Announces New Presentation Schedule

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has shared a recent update regarding its schedule at the Morgan Stanley 23rd Annual Global Healthcare Conference. The company will now present at 7:00 a.m. ET on the designated day for attendees and investors.

Webcast Availability

This presentation will be streamed live, and interested parties can easily access the webcast through the "Investors & Media" section of Regeneron's official website. Following the event, recorded replays alongside transcripts will be available online, ensuring that investors can revisit any part of the presentation they find important.

About Regeneron's Mission

Regeneron stands at the forefront as a biotechnology leader, committed to developing medicines that serve vital needs for patients suffering from serious health conditions. With a foundation built by physician-scientists, the company excels in turning scientific discoveries from their labs into tangible therapies.

Innovative Approaches in Medicine

The company’s expansive pipeline is focused on addressing a diverse range of diseases, whether they are related to the eyes, allergies, or various cancers. Regeneron is also advancing research in fields such as cardiovascular health, metabolism, and neurological conditions, highlighting their commitment to enhance patient health across multiple dimensions.

Technological Advancements

Regeneron harnesses innovative technology like VelociSuite, an operation that crafts optimized fully human antibodies and bispecific antibodies. The company leverages its proprietary tools and insights from its Genetics Center to spot new treatment targets while bolstering their drug development processes.

Community Engagement and Information Access

Those interested in the latest from Regeneron are encouraged to explore their website for further details. Additionally, investors can connect with the company on various social media platforms including LinkedIn, Instagram, and Facebook to stay up-to-date with ongoing projects, research, and breakthroughs.

Contact Information for Investors

If you have inquiries regarding investor relations, you may reach out to Ryan Crowe at 914-847-8790 or contact him via email at ryan.crowe@regeneron.com.

Frequently Asked Questions

What is the updated time for Regeneron's presentation?

The updated presentation time is now set for 7:00 a.m. ET at the Morgan Stanley 23rd Annual Global Healthcare Conference.

How can I access the presentation?

The presentation will be available via live webcast on Regeneron’s “Investors & Media” webpage.

What types of treatments does Regeneron focus on?

Regeneron develops treatments for various diseases, including those affecting the eyes, cancer, and cardiovascular health, among others.

What technologies does Regeneron employ in its research?

The company utilizes proprietary technology like VelociSuite to develop new medicines and therapeutic approaches.

Who can I contact for investor relations?

You can contact Ryan Crowe at 914-847-8790 or email him at ryan.crowe@regeneron.com.

About The Author

Hi there, As a writer and financial specialist, Henry Turner is passionate about guiding people through the complex world of finance. Having worked in finance for many years, I am an expert at simplifying difficult financial ideas into understandable, useful insights for my blog and articles. My goal is to arm you with the confidence and information you need to make wise financial choices.

Writing for a number of financial blogs has allowed me to interact with readers from novice investors looking for fresh ideas to seasoned investors starting their financial journeys. My mission is to enable everyone to understand and access finance, so enabling you to confidently and clearly reach your financial goals. I appreciate you traveling with me toward success and financial literacy.

Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.